Home Top Movers Companies Concepts

Market

Top Movers
Companies
Concepts

SEC Filings

AI Filing Analysis
Financial Reports
Current Reports
IPO Filings

Ownership

Institutional Holdings
Insider Trading

About

Data updates every 5 min
SEC EDGAR Source

© 2025–2026 StockGist|Information only, not investment advice

SCHEDULE 13G/A - Oramed Pharmaceuticals Inc. | StockGist | StockGist

Companies
ORMP
SCHEDULE 13G/A

Home Top Movers Companies Concepts

Home Filings ORMPSCHEDULE 13G/A

SCHEDULE 13G/A

Beneficial Ownership

Amendment

Oramed Pharmaceuticals Inc.

Filed Feb 9, 2026

Accepted Feb 9, 2026, 12:00 AM ET

CIK 0001176309

View on SEC.gov Company Profile

Beneficial Ownership Report

Passive Investment

Reporting Person

ORAMED PHARMACEUTICALS INC.

Person Type

PN

CUSIP: 68403P203

Recent Filings

Oramed Pharmaceuticals Inc.4 days ago

Oramed Pharmaceuticals Inc.1 months ago

Oramed Pharmaceuticals Inc.2 months ago

Oramed Pharmaceuticals Inc.2 months ago

Oramed Pharmaceuticals Inc.3 months ago

Data Sources

Original SEC Filing SEC EDGAR Company Page

Market

Top Movers
Companies
Concepts

SEC Filings

AI Filing Analysis
Financial Reports
Current Reports
IPO Filings

Ownership

Institutional Holdings
Insider Trading

About

Data updates every 5 min
SEC EDGAR Source

© 2025–2026 StockGist|Information only, not investment advice